Jens Lundgren, M.D., Discusses New Findings Regarding MI Risk of Specific Antiretrovirals (February 9, 2009)
The latest data from D:A:D indicate that lopinavir/ritonavir does increase myocardial infarction risk, but efavirenz, nevirapine and tenofovir do not. In this interview, Jens Lundgren, M.D., and HIV advocate Jeff Berry take part in a fascinating discussion on the new findings and their possible underlying causes.
In The 16th Conference on Retroviruses and Opportunistic Infections, from TheBodyPRO
TheBody is a service of Remedy Health Media, 461 Fifth Avenue, 14th Floor, New York, NY 10017. TheBody and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBody's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBody is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.